GO:0016569 | covalent chromatin modification | 12.96% (7/54) | 3.17 | 1.2e-05 | 0.001323 |
GO:0006139 | nucleobase-containing compound metabolic process | 31.48% (17/54) | 1.73 | 6e-06 | 0.001339 |
GO:0048831 | regulation of shoot system development | 12.96% (7/54) | 3.19 | 1.1e-05 | 0.001464 |
GO:0046483 | heterocycle metabolic process | 33.33% (18/54) | 1.61 | 1e-05 | 0.001552 |
GO:0016570 | histone modification | 12.96% (7/54) | 3.35 | 5e-06 | 0.001726 |
GO:0006807 | nitrogen compound metabolic process | 44.44% (24/54) | 1.2 | 2.3e-05 | 0.001884 |
GO:0034641 | cellular nitrogen compound metabolic process | 33.33% (18/54) | 1.52 | 2.1e-05 | 0.001979 |
GO:0043170 | macromolecule metabolic process | 40.74% (22/54) | 1.26 | 3.3e-05 | 0.002367 |
GO:0090304 | nucleic acid metabolic process | 27.78% (15/54) | 1.94 | 4e-06 | 0.002816 |
GO:0006325 | chromatin organization | 12.96% (7/54) | 2.76 | 7.2e-05 | 0.003143 |
GO:0009909 | regulation of flower development | 11.11% (6/54) | 3.1 | 7e-05 | 0.00326 |
GO:1901360 | organic cyclic compound metabolic process | 33.33% (18/54) | 1.4 | 6.7e-05 | 0.003339 |
GO:0044424 | intracellular part | 92.59% (50/54) | 0.4 | 6.4e-05 | 0.00347 |
GO:2000026 | regulation of multicellular organismal development | 12.96% (7/54) | 2.71 | 8.9e-05 | 0.003631 |
GO:0006725 | cellular aromatic compound metabolic process | 31.48% (17/54) | 1.39 | 0.00013 | 0.003683 |
GO:0051239 | regulation of multicellular organismal process | 12.96% (7/54) | 2.65 | 0.000119 | 0.003692 |
GO:0044260 | cellular macromolecule metabolic process | 33.33% (18/54) | 1.35 | 0.000109 | 0.003748 |
GO:0044238 | primary metabolic process | 48.15% (26/54) | 1.04 | 6.4e-05 | 0.003777 |
GO:0044237 | cellular metabolic process | 50.0% (27/54) | 0.97 | 9.9e-05 | 0.003804 |
GO:0006396 | RNA processing | 14.81% (8/54) | 2.39 | 0.000129 | 0.00381 |
GO:0044464 | cell part | 96.3% (52/54) | 0.32 | 0.000119 | 0.003858 |
GO:0006397 | mRNA processing | 7.41% (4/54) | 4.02 | 0.000109 | 0.003939 |
GO:0016070 | RNA metabolic process | 20.37% (11/54) | 2.02 | 6.3e-05 | 0.004127 |
GO:0048449 | floral organ formation | 7.41% (4/54) | 3.87 | 0.000163 | 0.004434 |
GO:2000241 | regulation of reproductive process | 11.11% (6/54) | 2.84 | 0.000183 | 0.004762 |
GO:0040029 | regulation of gene expression, epigenetic | 9.26% (5/54) | 3.2 | 0.000209 | 0.004868 |
GO:0008380 | RNA splicing | 9.26% (5/54) | 3.22 | 0.000196 | 0.004902 |
GO:0003006 | developmental process involved in reproduction | 22.22% (12/54) | 1.72 | 0.000205 | 0.004954 |
GO:0006479 | protein methylation | 9.26% (5/54) | 3.15 | 0.000246 | 0.005015 |
GO:0008213 | protein alkylation | 9.26% (5/54) | 3.15 | 0.000246 | 0.005015 |
GO:0016571 | histone methylation | 9.26% (5/54) | 3.17 | 0.000235 | 0.005273 |
GO:0000418 | RNA polymerase IV complex | 3.7% (2/54) | 6.42 | 0.000244 | 0.005293 |
GO:0010608 | posttranscriptional regulation of gene expression | 7.41% (4/54) | 3.68 | 0.000272 | 0.005374 |
GO:0000419 | RNA polymerase V complex | 3.7% (2/54) | 6.3 | 0.000288 | 0.005512 |
GO:0008152 | metabolic process | 51.85% (28/54) | 0.85 | 0.000304 | 0.005651 |
GO:0016246 | RNA interference | 5.56% (3/54) | 4.5 | 0.000322 | 0.005672 |
GO:0016458 | gene silencing | 9.26% (5/54) | 3.07 | 0.000316 | 0.005716 |
GO:0048580 | regulation of post-embryonic development | 11.11% (6/54) | 2.66 | 0.000357 | 0.00612 |
GO:0051567 | histone H3-K9 methylation | 7.41% (4/54) | 3.52 | 0.000417 | 0.006786 |
GO:0061647 | histone H3-K9 modification | 7.41% (4/54) | 3.52 | 0.000417 | 0.006786 |
GO:0035194 | posttranscriptional gene silencing by RNA | 5.56% (3/54) | 4.3 | 0.000483 | 0.007308 |
GO:0032259 | methylation | 11.11% (6/54) | 2.58 | 0.000481 | 0.007451 |
GO:0043414 | macromolecule methylation | 11.11% (6/54) | 2.58 | 0.000481 | 0.007451 |
GO:0018205 | peptidyl-lysine modification | 9.26% (5/54) | 2.91 | 0.000533 | 0.007718 |
GO:0044267 | cellular protein metabolic process | 22.22% (12/54) | 1.57 | 0.000526 | 0.007789 |
GO:1905393 | plant organ formation | 7.41% (4/54) | 3.4 | 0.000564 | 0.007818 |
GO:0071704 | organic substance metabolic process | 48.15% (26/54) | 0.86 | 0.000558 | 0.007898 |
GO:0006259 | DNA metabolic process | 12.96% (7/54) | 2.26 | 0.000604 | 0.008192 |
GO:0016441 | posttranscriptional gene silencing | 5.56% (3/54) | 4.14 | 0.000664 | 0.008825 |
GO:0000398 | mRNA splicing, via spliceosome | 5.56% (3/54) | 4.02 | 0.000858 | 0.01117 |
GO:0018193 | peptidyl-amino acid modification | 9.26% (5/54) | 2.67 | 0.001103 | 0.011971 |
GO:0009086 | methionine biosynthetic process | 5.56% (3/54) | 3.97 | 0.000939 | 0.011984 |
GO:0018022 | peptidyl-lysine methylation | 7.41% (4/54) | 3.14 | 0.001099 | 0.012123 |
GO:0000375 | RNA splicing, via transesterification reactions | 5.56% (3/54) | 3.86 | 0.001178 | 0.01217 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 5.56% (3/54) | 3.86 | 0.001178 | 0.01217 |
GO:0030880 | RNA polymerase complex | 3.7% (2/54) | 5.36 | 0.001091 | 0.012243 |
GO:0000428 | DNA-directed RNA polymerase complex | 3.7% (2/54) | 5.36 | 0.001091 | 0.012243 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3.7% (2/54) | 5.36 | 0.001091 | 0.012243 |
GO:0045814 | negative regulation of gene expression, epigenetic | 7.41% (4/54) | 3.1 | 0.001226 | 0.01247 |
GO:0031047 | gene silencing by RNA | 7.41% (4/54) | 3.18 | 0.000997 | 0.012485 |
GO:0006342 | chromatin silencing | 7.41% (4/54) | 3.12 | 0.00117 | 0.012489 |
GO:0022414 | reproductive process | 22.22% (12/54) | 1.46 | 0.001036 | 0.012723 |
GO:0006555 | methionine metabolic process | 5.56% (3/54) | 3.9 | 0.001084 | 0.012832 |
GO:0006464 | cellular protein modification process | 18.52% (10/54) | 1.62 | 0.001314 | 0.012964 |
GO:0036211 | protein modification process | 18.52% (10/54) | 1.62 | 0.001314 | 0.012964 |
GO:0034968 | histone lysine methylation | 7.41% (4/54) | 3.15 | 0.001081 | 0.013036 |
GO:0009067 | aspartate family amino acid biosynthetic process | 5.56% (3/54) | 3.73 | 0.001526 | 0.014612 |
GO:0050793 | regulation of developmental process | 12.96% (7/54) | 2.03 | 0.001514 | 0.014707 |
GO:0009892 | negative regulation of metabolic process | 11.11% (6/54) | 2.23 | 0.001684 | 0.015889 |
GO:0043412 | macromolecule modification | 20.37% (11/54) | 1.46 | 0.001723 | 0.016027 |
GO:0043231 | intracellular membrane-bounded organelle | 79.63% (43/54) | 0.41 | 0.001777 | 0.016292 |
GO:0010420 | polyprenyldihydroxybenzoate methyltransferase activity | 1.85% (1/54) | 9.0 | 0.001953 | 0.016509 |
GO:0004639 | phosphoribosylaminoimidazolesuccinocarboxamide synthase activity | 1.85% (1/54) | 9.0 | 0.001953 | 0.016509 |
GO:0010426 | DNA methylation on cytosine within a CHH sequence | 1.85% (1/54) | 9.0 | 0.001953 | 0.016509 |
GO:0051325 | interphase | 1.85% (1/54) | 9.0 | 0.001953 | 0.016509 |
GO:0004395 | hexaprenyldihydroxybenzoate methyltransferase activity | 1.85% (1/54) | 9.0 | 0.001953 | 0.016509 |
GO:0048519 | negative regulation of biological process | 14.81% (8/54) | 1.79 | 0.002012 | 0.01679 |
GO:0043227 | membrane-bounded organelle | 79.63% (43/54) | 0.41 | 0.001859 | 0.016809 |
GO:0043226 | organelle | 79.63% (43/54) | 0.39 | 0.002522 | 0.020525 |
GO:0009066 | aspartate family amino acid metabolic process | 5.56% (3/54) | 3.47 | 0.002555 | 0.020538 |
GO:0043229 | intracellular organelle | 79.63% (43/54) | 0.39 | 0.002498 | 0.020582 |
GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation | 5.56% (3/54) | 3.44 | 0.002715 | 0.021551 |
GO:0032774 | RNA biosynthetic process | 7.41% (4/54) | 2.76 | 0.002871 | 0.022514 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 7.41% (4/54) | 2.75 | 0.002939 | 0.022779 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 3.7% (2/54) | 4.61 | 0.003065 | 0.023473 |
GO:0016074 | snoRNA metabolic process | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0001682 | tRNA 5'-leader removal | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0034471 | ncRNA 5'-end processing | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0043144 | snoRNA processing | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0099116 | tRNA 5'-end processing | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0046400 | keto-3-deoxy-D-manno-octulosonic acid metabolic process | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0019294 | keto-3-deoxy-D-manno-octulosonic acid biosynthetic process | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0008676 | 3-deoxy-8-phosphooctulonate synthase activity | 1.85% (1/54) | 8.0 | 0.003902 | 0.027311 |
GO:0010629 | negative regulation of gene expression | 9.26% (5/54) | 2.21 | 0.0044 | 0.030151 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 11.11% (6/54) | 1.95 | 0.004372 | 0.030277 |
GO:1901564 | organonitrogen compound metabolic process | 29.63% (16/54) | 0.98 | 0.00473 | 0.031746 |
GO:0016071 | mRNA metabolic process | 7.41% (4/54) | 2.56 | 0.004703 | 0.031894 |
GO:0006305 | DNA alkylation | 5.56% (3/54) | 3.09 | 0.005272 | 0.03467 |
GO:0006306 | DNA methylation | 5.56% (3/54) | 3.09 | 0.005272 | 0.03467 |
GO:0044728 | DNA methylation or demethylation | 5.56% (3/54) | 3.08 | 0.005436 | 0.035389 |
GO:0006304 | DNA modification | 5.56% (3/54) | 3.07 | 0.005519 | 0.035574 |
GO:0031538 | negative regulation of anthocyanin metabolic process | 1.85% (1/54) | 7.42 | 0.005847 | 0.035907 |
GO:0000966 | RNA 5'-end processing | 1.85% (1/54) | 7.42 | 0.005847 | 0.035907 |
GO:0005663 | DNA replication factor C complex | 1.85% (1/54) | 7.42 | 0.005847 | 0.035907 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 14.81% (8/54) | 1.54 | 0.005689 | 0.03631 |
GO:0032502 | developmental process | 25.93% (14/54) | 1.05 | 0.005762 | 0.036417 |
GO:0019538 | protein metabolic process | 22.22% (12/54) | 1.15 | 0.006319 | 0.038444 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 7.41% (4/54) | 2.42 | 0.006701 | 0.03966 |
GO:0045892 | negative regulation of transcription, DNA-templated | 7.41% (4/54) | 2.42 | 0.006701 | 0.03966 |
GO:1902679 | negative regulation of RNA biosynthetic process | 7.41% (4/54) | 2.42 | 0.006701 | 0.03966 |
GO:0018130 | heterocycle biosynthetic process | 12.96% (7/54) | 1.63 | 0.007112 | 0.04097 |
GO:0006270 | DNA replication initiation | 3.7% (2/54) | 3.98 | 0.007195 | 0.041086 |
GO:0051253 | negative regulation of RNA metabolic process | 7.41% (4/54) | 2.39 | 0.007071 | 0.0411 |
GO:0007275 | multicellular organism development | 11.11% (6/54) | 1.81 | 0.007037 | 0.041269 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 7.41% (4/54) | 2.35 | 0.00785 | 0.04155 |
GO:0031053 | primary miRNA processing | 1.85% (1/54) | 7.0 | 0.007788 | 0.041558 |
GO:0000339 | RNA cap binding | 1.85% (1/54) | 7.0 | 0.007788 | 0.041558 |
GO:0033588 | Elongator holoenzyme complex | 1.85% (1/54) | 7.0 | 0.007788 | 0.041558 |
GO:0031386 | protein tag | 1.85% (1/54) | 7.0 | 0.007788 | 0.041558 |
GO:0043433 | negative regulation of DNA-binding transcription factor activity | 1.85% (1/54) | 7.0 | 0.007788 | 0.041558 |
GO:0010605 | negative regulation of macromolecule metabolic process | 9.26% (5/54) | 2.03 | 0.007374 | 0.041741 |
GO:0048856 | anatomical structure development | 16.67% (9/54) | 1.35 | 0.008027 | 0.041802 |
GO:0009987 | cellular process | 51.85% (28/54) | 0.57 | 0.007998 | 0.041989 |
GO:0032446 | protein modification by small protein conjugation | 5.56% (3/54) | 2.86 | 0.00816 | 0.042162 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 7.41% (4/54) | 2.36 | 0.00765 | 0.042568 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 7.41% (4/54) | 2.36 | 0.00765 | 0.042568 |
GO:0031327 | negative regulation of cellular biosynthetic process | 7.41% (4/54) | 2.32 | 0.00833 | 0.0427 |
GO:0009890 | negative regulation of biosynthetic process | 7.41% (4/54) | 2.31 | 0.008613 | 0.043804 |
GO:0005634 | nucleus | 50.0% (27/54) | 0.58 | 0.008965 | 0.04524 |
GO:0031109 | microtubule polymerization or depolymerization | 1.85% (1/54) | 6.68 | 0.009726 | 0.04725 |
GO:0010306 | rhamnogalacturonan II biosynthetic process | 1.85% (1/54) | 6.68 | 0.009726 | 0.04725 |
GO:0051090 | regulation of DNA-binding transcription factor activity | 1.85% (1/54) | 6.68 | 0.009726 | 0.04725 |
GO:0010396 | rhamnogalacturonan II metabolic process | 1.85% (1/54) | 6.68 | 0.009726 | 0.04725 |
GO:0046785 | microtubule polymerization | 1.85% (1/54) | 6.68 | 0.009726 | 0.04725 |